Changes in serum estrogenic activity during neoadjuvant therapy with letrozole and exemestane

The Journal of Steroid Biochemistry and Molecular Biology
N BahramiJ Geisler

Abstract

The aromatase inhibitors (AIs), letrozole (Femar®/Femara®) and exemestane (Aromasin®), are widely used to treat estrogen receptor (ER) positive breast cancer in postmenopausal patients. In the setting of metastatic breast cancer, these drugs may be used after another causing new responses in selected patients after progressing on the first choice. The precise explanation for this "lack of cross resistance" is still missing. NEOLETEXE is a neoadjuvant, randomized, open-label, cross-over trial. Postmenopausal patients with ER-positive, HER-2 negative, locally advanced breast cancer were enrolled. All patients were randomized to treatment starting with either letrozole or exemestane for at least 2 months followed by another 2 months on the alternative AI. The total estrogenic activities in blood samples were determined using the AroER tri-screen assay developed in the Chen laboratory. Using this highly sensitive assay, estrogenic activity was detected at three time points for all patients. Importantly, a significantly higher total estrogenic activity was found during therapy with exemestane compared to letrozole in 21 out of 26 patients. When letrozole was included in the AroER tri-screen assay, the estrogenic activities in most s...Continue Reading

Citations

Nov 19, 2020·Breast Cancer : Targets and Therapy·Andrea Luque-BolivarMilena Rondón-Lagos
Aug 14, 2021·Frontiers in Endocrinology·Tara HyderAdam M Brufsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Related Papers

Expert Opinion on Drug Metabolism & Toxicology
P E Lønning, J Geisler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Danijela JelovacAngela M H Brodie
Endocrine-related Cancer
Kathleen Van AstenRobert Paridaens
Cancer Control : Journal of the Moffitt Cancer Center
W R Miller, J M Dixon
© 2021 Meta ULC. All rights reserved